Breakthrough Chemistry (BKTH) Stock Statistics & Valuation Metrics

Breakthrough Chemistry has a market cap or net worth of $2.02M. The enterprise value is $2.64M.

Breakthrough Chemistry has 9,729,304 shares outstanding. The number of shares has decreased by -2.65% in one year.

Breakthrough Chemistry’s return on equity (ROE) is 0.75 and return on invested capital (ROIC) is -6.59%.

The current PE Ratio of Breakthrough Chemistry is 5.8. Breakthrough Chemistry’s PEG ratio is -0.00008.

In the last 12 months, Breakthrough Chemistry had revenue of 15.07K and earned 1.44M in profits. Earnings per share was 0.15.

In the last 12 months, operating cash flow was -13.11K and capital expenditures 5.00, giving a free cash flow of -13.11K billion.

Breakthrough Chemistry pays an annual dividend of ―, resulting in a dividend yield of ―

Breakthrough Chemistry upcoming earnings date is ―, ―.

Breakthrough Chemistry as a current ratio of 6.17, with Debt / Equity ratio of 23.35%

In the past 12 months, Breakthrough Chemistry has paid 0.00 in taxes.

Breakthrough Chemistry EV to EBITDA ratio is -5.38, with an EV/FCF ratio of -43.97.

Breakthrough Chemistry has $1.91M in cash and marketable securities with $195.38K in debt, giving a net cash position of $1.71M billion.

Gross margin is -80.23%, with operating margin of -963.87%, and net profit margin of 9569.50%.

The average price target for Breakthrough Chemistry is ―, which is 11.43% higher than the current price. The consensus rating is ―